Launch
Website- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Specialises in
- Benign Prostate disorders
- General urology
- Urological oncology
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Mr Chris Blick is a consultant urological and robotic surgeon who has a subspeciality interest in benign prostate conditions and urological cancers.
He is a key opinion leader in novel surgical technologies and in the treatment of benign prostatic enlargement offering Aquablation, Rezum, iTind and Echolaser as well as TURP. He is among the UK's highest volume aquablation surgeons and has presented his outcome data internationally.
Mr Blick has extensive experience in the management of inflammatory conditions and infections affecting the urinary tract and prostate (prostatitis). He contributed to landmark clinical trials demonstrating the efficacy of the uromune vaccine in recurrent urinary tract infections.
With over a decade of experience in robotic surgery, Mr Blick routinely performs complex procedures using the Da Vinci surgical system, including nephrectomy (kidney removal), partial nephrectomy, pyeloplasty, partial cystectomy, and ureteric re-implantation.
Deeply involved in clinical research, Mr Blick became the first urological trainee member of the National Institute of Heath Research (NIHR) clinical studies group (CSG). He has been a member of the national renal and bladder cancer CSG, the screening and early prevention (SPED) group and the UK cancer screening and early prevention group of the NIHR.
Mr Blick is the Research and Development Lead in Urology at the Royal Berkshire Hospital. He has recently received funding and was Chief Investigator in the TARGET trial using augmented reality and artificial intelligence in the diagnosis of prostate cancer. He currently runs a PhD programme evaluating the role of remote monitoring, machine learning and AI in Urological conditions.
In addition, Mr Blick is the UK Chief Investigator for the EASE trial, evaluating active surveillance in renal cancer, and serves as Principal Investigator for several national and international studies in bladder, renal, and prostate cancer.
Areas of interest
haematuria; flexible cystoscopy; cystoscopy; haematospermia; bladder cancer; renal cancer; prostate cancer; dysuria; prostatitis; PSA; prostate health; urinary symptoms; bladder pain; recurrent UTI; UTI; aquablation; rezum; urolift; TURP; itind, echolaser, bladder neck incision; robotic partial nephrectomy; PUJ obstruction; Laparoscopic surgery; Robotic surgery; Nephrectomy; Cystectomy; Distal ureterectomy; ureteric reimplantation; erectile dysfunction; bacterial prostatitis; phimosis; conditions of foreskin and scrotum; hydroceles; epididymal cysts; scrotal swelling; testicular cancer; testicular lumps; benign prostatic enlargement; cystitis; interstitial cystitis; urethral pain; pelvic pain; nocturia; bladder overactivity; bladder outflow obstruction; endoscopic management of bladder outflow obstruction;
Medical secretaries
- Jessica Powell
- 11 Kendrick Road Reading RG1 5DU
- 0118 920 7045
- 0118 920 7040
- jessica.powell@theforburyclinic.co.uk
Anaesthetists worked with
- Dr Claire Seeley
Fee Assured
- Dr Carl S Waldmann
Not Fee Assured
- Dr Elizabeth Brannigan
Fee Assured
- Dr Douglas G Barker
Fee Assured
- Dr Richard Barnes
Not Fee Assured
Information for healthcare professionals (Bupa patients only, last 12 months)
-
20365
Follow-up out-patient consultation - remote - (>50)
-
M4510
Diagnostic endoscopic examination of bladder (flexible cystoscopy) +/- any biopsy - (5-50)
Berkshire Health Limited (5-50)
-
M4712
Bladder instillation of pharmacologic agent (including cystoscopy) - (5-50)
Berkshire Health Limited (5-50)
-
M6530
Endoscopic resection of prostate (TUR) (including cystoscopy) - (5-50)
-
M6583
Transperineal MRI - US fusion targeted prostate biopsy - (1-5)
Berkshire Health Limited (1-5) Ramsay Berkshire Independent Hospital (1-5)
- Show All (10 )...